Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 18,811 | 2,725 | 2,212 | N/A |
| Depreciation Amortization | N/A | 9,076 | 5,934 | 2,954 | N/A |
| Income taxes - deferred | N/A | -9,055 | 1,364 | 1,150 | N/A |
| Accounts receivable | N/A | -3,355 | -9,273 | -768 | N/A |
| Accounts payable and accrued liabilities | N/A | 11,575 | 13,621 | 4,664 | N/A |
| Other Working Capital | N/A | 363 | -3,508 | -2,914 | N/A |
| Other Operating Activity | 0 | -7,115 | -4,527 | -3,848 | 0 |
| Operating Cash Flow | $N/A | $20,300 | $6,336 | $3,450 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -20,647 | -9,364 | -5,684 | N/A |
| Other Investing Activity | 0 | -2,099 | -2,099 | -1,185 | 0 |
| Investing Cash Flow | $N/A | $-22,746 | $-11,463 | $-6,869 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 18,000 | 14,500 | 10,500 | N/A |
| Debt Repayment | N/A | -3,805 | -2,543 | -1,271 | N/A |
| Common Stock Issued | N/A | 1 | 1 | 1 | N/A |
| Other Financing Activity | 0 | -9,509 | -7,871 | -3,029 | 0 |
| Financing Cash Flow | $N/A | $4,687 | $4,087 | $6,201 | $N/A |
| Beginning Cash Position | N/A | 5,734 | 5,734 | 5,734 | N/A |
| End Cash Position | N/A | 7,975 | 4,694 | 8,516 | N/A |
| Net Cash Flow | $N/A | $2,241 | $-1,040 | $2,782 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 20,300 | 6,336 | 3,450 | N/A |
| Capital Expenditure | N/A | -20,735 | -9,437 | -5,727 | N/A |
| Free Cash Flow | 0 | -435 | -3,101 | -2,277 | 0 |